Development of a brain metastatic canine prostate cancer cell line
- 14 February 2011
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 71 (12), 1251-1263
- https://doi.org/10.1002/pros.21341
Abstract
Prostate cancer in men has a high mortality and morbidity due to metastatic disease. The pathobiology of prostate cancer metastasis is not well understood and cell lines and animal models that recapitulate the complex nature of the disease are needed. Therefore, the goal of the study was to establish and characterize a new prostate cancer line derived from a dog with spontaneous prostate cancer. A new cell line (Leo) was derived from a dog with spontaneous prostate cancer. Immunohistochemistry and PCR were used to characterize the primary prostate cancer and xenografts in nude mice. Subcutaneous tumor growth and metastases in nude mice were evaluated by bioluminescent imaging, radiography and histopathology. In vitro chemosensitivity of Leo cells to therapeutic agents was measured. Leo cells expressed the secretory epithelial cytokeratins (CK)8, 18, and ductal cell marker, CK7. The cell line grew in vitro (over 75 passages) and was tumorigenic in the subcutis of nude mice. Following intracardiac injection, Leo cells metastasized to the brain, spinal cord, bone, and adrenal gland. The incidence of metastases was greatest to the central nervous system (80%) with a lower incidence to bone (20%) and the adrenal glands (16%). In vitro chemosensitivity assays demonstrated that Leo cells were sensitive to Velcade and an HDAC-42 inhibitor with IC(50) concentrations of 1.9 nm and 0.95 µm, respectively. The new prostate cancer cell line (Leo) will be a valuable model to investigate the mechanisms of the brain and bone metastases.Keywords
Funding Information
- National Cancer Institute (2P01 CA93900)
- The Ohio State University College of Veterinary Medicine (520026)
This publication has 46 references indexed in Scilit:
- A genome assembly-integrated dog 1 Mb BAC microarray: a cytogenetic resource for canine cancer studies and comparative genomic analysisCytogenetic and Genome Research, 2008
- The cell culture expansion of bone marrow stromal cells from humans with spinal cord injury: implications for future cell transplantation therapySpinal Cord, 2008
- Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesionsThe Prostate, 2008
- NOD/SCID mouse model of canine T‐cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imagingVeterinary and Comparative Oncology, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to boneBJU International, 2007
- In silico identification and Bayesian phylogenetic analysis of multiple new mammalian kallikrein gene familiesGenomics, 2006
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 2004
- Exploration, normalization, and summaries of high density oligonucleotide array probe level dataBiostatistics, 2003
- Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone‐stimulated growth; and the ductal origin of carcinomaThe Prostate, 2001